具核梭杆菌通过下调LCN2促进结直肠癌细胞增殖和迁移

doi:10.3969/j.issn.1009-976X.2020.04.001

摘要/Abstract

摘要： 目的探究具核梭杆菌（Fn）对结直肠癌细胞的影响机制。方法研究对象来自深圳市人民医院门诊的肠镜受检者,共选取15例结直肠癌患者（按术前与术后分组）,和15例无结直肠疾病的肠镜受检者（健康组）,qPCR检测粪便样品中具核梭杆菌的丰度;CCK-8和Transwell分别检测具核梭杆菌对结直肠癌细胞（HCT116、SW480）增殖和迁移侵袭的影响;转录组微阵列分析具核梭杆菌对结直肠癌细胞相关基因表达的影响;筛选差异基因,并加以功能验证。结果 qPCR结果显示具核梭杆菌在术前组中的丰度显著高于术后组和健康组;具核梭杆菌能够促进结直肠癌细胞增殖、迁移和侵袭;微阵列分析结果显示脂质运载蛋白-2（LCN2）mRNA相对含量在具核梭杆菌感染的结直肠癌细胞中显著下调。过表达LCN2能够抑制结直肠癌细胞增殖活性和迁移侵袭能力,而具核梭杆菌能够可以抑制LCN2的mRNA和蛋白表达,减弱LCN2对结直肠癌细胞的抑制效应。结论具核梭杆菌能够通过下调LCN2的表达来促进结直肠癌细胞增殖和迁移侵袭能力,为LCN2作为预防和治疗与具核梭杆菌相关的结直肠癌的靶点提供了相关理论依据。

关键词: 具核梭杆菌, 结直肠癌, LCN2, 迁移, 增殖, 侵袭

Abstract: Objective To explore the effects and potential mechanism of Fusobacterium nucleatum （Fn） on colorectal cancer cells. Methods The subjects were from the patients who underwent colonoscopy in the outpatient department of Shenzhen People's Hospital. A total of 15 patients with colorectal cancer （grouped according to preoperative and postoperative） and 15 people with colonoscopy without colorectal diseasewere selected. qPCR was performed to detect the abundance of Fn in fecal samples. The proliferation, migration and invasion of colorectal cancer cells （HCT116, SW480） were detected by CCK-8 and transwell assay. The expression of related genes to colorectal cancercells was analyzed by whole transcriptome microarray after infecting with Fn. Screening and functional verification of significant differential genes. Results the composition of intestinal flora in operated group was close to that in healthy group. The Fn abundancein CRC group was significantly higherthan that in both operated group and healthy group. Fn can promote the proliferation, migration and invasion of colorectal cancer cells. Microarray analysis showed that LCN2 was the most differentially expressed gene after Fn infection in colorectal cancer cells. Overexpression of LCN2 inhibited the proliferation activity and migration and invasion ability of colorectal cancer cells, Fn reduced the inhibitory effect of LCN2 on colorectal cancer cells. Conclusion Fn can promote the proliferation and migration of colorectal cancer cells by down-regulating the expression of LCN2, which provide some supports for LCN2 to be a prevention and treatment target for Fn-related colorectal cancer

Key words: Fusobacterium nucleatum （Fn）, proliferation, invasion, migration, LCN2, colorectal cancer

中图分类号:

R735.3+7

朱畅, 傅宇翔, 夏利刚, 李方, 黄凯斌, 孙逍. 具核梭杆菌通过下调LCN2促进结直肠癌细胞增殖和迁移[J]. 岭南现代临床外科, 2020, 20(04): 411-415.

ZHU Chang, FU Yu-xiang, XIA Li-gang, LI Fang, HUANG Kai-bin, SUN Xiao. Fusobacterium nucleatum promotes proliferation and migration of colorectal cancer cells by down-regulating of LCN2 expression[J]. Lingnan Modern Clinics in Surgery, 2020, 20(04): 411-415.

参考文献

[1] Bingham S A.Diet and colorectal cancer prevention[J]. Biochem Soc Trans, 2000,28(2):12-16.
[2] Magalhães B, Peleteiro B, Lunet N.Dietary patterns and colorectal cancer: systematic review and meta-analysis[J]. Eur J Cancer Prev, 2012,21(1):15-23.
[3] Tilg H, Adolph TE, Gerner RR, et al.The Intestinal Microbiota in Colorectal Cancer[J]. Cancer Cell, 2018,33(6):954-964.
[4] Lam SY, Yu J, Wong SH, et al.The gastrointestinal microbiota and its role in oncogenesis[J]. Best Pract Res Clin Gastroenterol, 2017,31(6):607-618.
[8] Yang HJ, Kwon MJ, Chang Y, et al.Fecal microbiota differences according to the risk of advanced colorectal neoplasms[J]. J Clin Gastroenterol, 2019,53(3):197-203.
[6] Mima K, Ogino S, Nakagawa S, et al.The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms[J]. Surg Oncol, 2017,26(4):368-376.
[7] Wroblewski LE, Peek RM Jr, Coburn LA.The Role of the Microbiome in Gastrointestinal Cancer[J]. Gastroenterol Clin North Am, 2016,45(3):543-556.
[8] Arumugam M, Raes J, Pelletier E, et al.Enterotypes of the human gut microbiome[J]. Nature, 2011,473(7346):174-180.
[9] Gill SR, Pop M, Deboy RT, et al.Metagenomic analysis of the human distal gut microbiome[J]. Science, 2006,312(5778):1355-1359.
[10] Eckburg PB, Bik EM, Bernstein CN, et al.Diversity of the human intestinal microbial flora[J]. Science, 2005,308(5728):1635-1638.
[11] Zheng J, Gänzle MG, Lin XB, et al.Diversity and dynamics of bacteriocins from human microbiome[J]. Environ Microbiol, 2015,17(6):2133-2143.
[12] Gao Z, Guo B, Gao R, et al.Microbiota disbiosis is associated with colorectal cancer[J]. Front Microbiol, 2015,6:20.
[13] Gethings-Behncke C, Coleman HG, Jordao HWT, et al.Fusobacterium nucleatum in the colorectum and its association withcancerrisk and survival: a systematic review and meta-analysis[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(3): 539-548.
[14] Chen S, Su T, Zhang Y, et al.Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7[J]. Gut Microbes, 2020, 11(3):511-525
[15] Sun CH, Li BB, Wang B, et al.The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management[J]. Chronic Dis Transl Med, 2019, 5(3):178-187.
[16] Kostic AD, Gevers D, Pedamallu CS, et al.Genomic analysis identifies association of Fusobacterium with colorectal carcinoma[J]. Genome Res, 2012,22(2):292-298.
[17] Castellarin M, Warren RL, Freeman JD, et al.Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma[J]. Genome Res, 2012,22(2):299-306.
[18] Zhang S, Yang Y, Weng W,et al.Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer[J]. J Exp Clin Cancer Res,2019,38(1):14.
[19] Richards AL, Muehlbauer AL, Alazizi A, et al.Gut Microbiota Has a Widespread and Modifiable Effect on Host Gene Regulation[J]. mSystems, 2019,4(5): e00323-18.
[20] Watson AJ, Hall LJ.Regulation of host gene expression by gut microbiota[J]. Gastroenterology, 2013,144(4):841-844.
[21] Rahimi S, Roushandeh AM, Ebrahimi A, et al.CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells[J]. Life Sci, 2019,231:116586.
[22] Feng M, Feng J, Chen W,et al.Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition[J]. Mol Cancer,2016,15(1):77.
[23] Kim SL, Lee ST, Min IS,et al.Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer[J]. Cancer Sci,2017,108(11):2176-2186.

[1]	徐润强, 刘宇平, 张海良, 刘海盛, 刘钰君, 姚金科. VEGF-A及PI3K/AKT通路在结直肠癌中的表达及临床意义[J]. 岭南现代临床外科, 2021, 21(06): 603-607.
[2]	马晓武, 谭文亮, 杨磊, 谢智钦, 王庆斌, 陈亚进, 商昌珍. 环状RNA circKDM4B调控肝癌细胞增殖及侵袭迁移的实验研究[J]. 岭南现代临床外科, 2021, 21(06): 614-619.
[3]	唐兴奎, 林玉坤, 何嘉琳, 罗喜俊, 梁俊杰, 朱显军. 广泛型线粒体肌酸激酶基因在结直肠癌中的表达及生物学意义[J]. 岭南现代临床外科, 2021, 21(05): 535-540.
[4]	吴毅, 刘付宁, 严颖哲, 杨浩杰, 谢乾. 利多卡因抑制ERK信号通路激活降低甲状腺癌细胞TPC-1的增殖能力[J]. 岭南现代临床外科, 2021, 21(03): 294-297.
[5]	钟启宇, 谢文练. circZBTB44通过调控AKT通路促进肾透明细胞癌增殖和迁移的研究[J]. 岭南现代临床外科, 2021, 21(03): 302-308.
[6]	曾兵, 李锦宏, 蔡灿锋, 辛海洋, 曾军. ITGAV在结直肠癌中的表达及临床意义[J]. 岭南现代临床外科, 2021, 21(03): 309-312.
[7]	张果, 张瑞, 陈进宏. 结直肠癌肝转移预后评分系统的现状及临床应用[J]. 岭南现代临床外科, 2021, 21(01): 11-16.
[8]	黄贻培, 罗伟鑫, 许磊波. 转录因子YY1在肝细胞癌中的表达和功能研究[J]. 岭南现代临床外科, 2021, 21(01): 44-52.
[9]	任宝军, 剧永乐, 封静, 陈淑香, 刘家旋, 罗振涛, 王家智, 杨帆, 李德智, 董博业, 耿岩. Aurora A激酶抑制剂Alisertib诱导结直肠癌细胞自噬的作用及与p53表达间的关系[J]. 岭南现代临床外科, 2021, 21(01): 82-86.
[10]	李俊, 狄茂军, 谭华勇, 唐强. 经肛减压导管置入处理结直肠癌并急性梗阻的临床观察[J]. 岭南现代临床外科, 2020, 20(05): 573-576.
[11]	顾威庭, 赵俊文, 赵东明, 成侃, 蔡瑜. 微侵袭血肿清除术对高血压脑出血患者术后神经功能恢复及并发症的影响[J]. 岭南现代临床外科, 2020, 20(04): 463-467.
[12]	姬路鹏, 彭安萍, 张毅, 梁庭都. POLE2对非小细胞肺癌细胞侵袭迁移能力的影响[J]. 岭南现代临床外科, 2020, 20(03): 307-310.
[13]	陈志良, 谢文练. circDOCK4促进肾透明细胞癌细胞增殖、迁移和侵袭的研究[J]. 岭南现代临床外科, 2020, 20(02): 139-145.
[14]	姚奇, 何兰珍. 基于数据库挖掘分析COL4A1基因在结直肠癌中的表达及意义[J]. 岭南现代临床外科, 2020, 20(02): 167-171.
[15]	叶惠荣，吴丽华，张玉娟，高学忠，王西跃，曹茵. 灵菌红素通过促进Bim调控人乳腺癌细胞凋亡[J]. 岭南现代临床外科, 2020, 20(01): 38-43.